Chirantan Chatterjee

Visiting Fellow

Chirantan Chatterjee is a visiting fellow at the Hoover Institution. Chatterjee was previously the Edward Teller National Fellow at the Hoover Institution.

Chatterjee is an economist with research interests in economics of innovation, applied microeconomics, pharmaceutical economics, and global health. He is currently an Associate Professor in Business Policy and Economics at the Indian Institute of Management, Ahmedabad where he also holds the ICICI Bank Chair in Strategic Management. He has been published in top peer- reviewed journals like the RAND Journal of Economics, the Journal of Health Economics, the Journal of Law & Economics, Research Policy, Production and Operations Management, the Journal of Business Ethics, Social Science & Medicine, Health Policy and Planning, Economic and Political Weekly, and the Journal of Antitrust Enforcement. He has also published for Brookings Press, Oxford University Press (India), and the National Bureau of Economic Research (NBER).

Chatterjee’s dissertation work on the economics of innovation and intellectual property (IP) in the global pharmaceutical industry was supported by the National Science Foundation (NSF), and in 2015 his research was cited on NSF’s Science of Science Policy website. In 2017, Chatterjee was invited to chair the round table on IP and Access to Medicines at the 2017 Annual Conference of European Policy for Intellectual Property in Bordeaux France.

Chatterjee has also consulted with the World Bank and the Competition Commission of India. His input has been cited in a 2015 Tarun Khanna Committee Report by the National Institution for Transforming India (NITI) Aayog, currently India's central planning authority, also formulating innovation and entrepreneurship policy for the Indian economy. At the Indian Institute of Management (IIM) Bangalore, where he was previously a faculty member between 2011–16, Chatterjee conceptualized and chaired the First India Conference on Innovation, Intellectual Property and Competition, a first of its kind international innovation policy conference in India. This conference convened again in 2018 with Chatterjee cochairing the event as a faculty member in economics and public policy at the Indian School of Business, where he also was the Bharti Institute and Max Institute Research Fellow in Public Policy and Healthcare.

Chatterjee's deep passion about Indian healthcare markets and for democratizing education has also resulted in the first ever MOOC on health care markets in India in 2016, available through edX. In his spare time, he regularly contributes op-eds on economics and public policy issues for national dailies like LiveMint, Economic Times, Times of India, Hindu Business Line, and the Hindustan Times and tweets @chiruchat. He earned a PhD and an MPhil in public policy and management from the Carnegie Mellon University in 2011. Prior to his doctoral education, Chatterjee worked as a business journalist for the Economic Times, India’s leading business daily after earning his BTech (civil engineering) from the Indian Institute of Technology, Roorkee and MBA from the Indian Institute of Management Calcutta.

Filter By:



Recent Commentary

Analysis and Commentary

Dear Parents: Don't Let Superstar Syndrome Set Kids Up To Fail

by Chirantan Chatterjeevia The Hill
Friday, September 17, 2021

British tennis star Emma Raducanu has won the U.S. Open at 18 years-old, and the media has started gushing. She also has an A plus in Math and A in Economics. Wow, this is why immigrants rock! Canadian born British teen with Romanian and Chinese heritage — what a combination!

Analysis and Commentary

Naming & Shaming Of Infosys And India's Fall Into A Moral Abyss

by Chirantan Chatterjeevia Deccan Herald
Tuesday, September 14, 2021

The naming and shaming of Infosys, India's post-liberalisation poster child software company by Panchjanya, apparently has sent shockwaves in the industry.

Analysis and Commentary

Intellectual Property Regimes And Wage Inequality

by Chirantan Chatterjeevia Journal of Development Economics
Monday, July 19, 2021

Does stronger intellectual property (IP) cause wage inequality? This question in a post Covid-19 & AI world where digitization and technology (along with patent waiver debates for vaccines) are all pervasive is of increasing global importance.

Analysis and Commentary

Rise Of Shadow Entrepreneurship

by Chirantan Chatterjeevia The Hindu
Monday, January 18, 2021

[Subscription Required] Without regulation, the situation could spiral out of control.

Analysis and CommentaryBlank Section (Placeholder)

COVID-19 And Beyond: The Necessity Of Creating A Global Health Policy Trifecta

by Chirantan Chatterjeevia The Wire Science
Sunday, April 12, 2020

It has become clear that by the time the world has dealt with COVID-19, a large chunk of 2020 will have passed and severe economic and healthcare costs will have been incurred globally whatever is the optimal choice made by countries between testing and social distancing.

Analysis and Commentary

Quite A Vexing Equation

by Chirantan Chatterjeevia The Telegraph
Friday, December 13, 2019

How does fear, lack of trust impact economic growth?

Analysis and Commentary

Data Security, Data Breaches, And Compliance

by Chirantan Chatterjee, D. Daniel Sokolvia SSRN
Sunday, November 17, 2019

This chapter explores the attributes of compliance in the context of data breaches. First, it identifies the sort of corporate governance problem that data breaches create. Then, it approaches the empirical work related to data breaches and to the organization of compliance-based responses in terms of risk assessment, training and compliance, both preemptively and after a breach.

Analysis and Commentary

The 2019 Nobel Prizes Send Out Mixed Messages

by Chirantan Chatterjeevia The Telegraph
Friday, October 25, 2019

The world is going through a morality conundrum. This year’s Nobel Prizes reflect this as well.

Bad Medicine: The Value Of Monitoring Banned Drugs

by Chirantan Chatterjee
Wednesday, August 28, 2019

These are tough times around the world when it comes to regulating flawed medicines that are banned from the marketplace. Last month, the Washington Post reported details from a DEA database of 76 billion opioid pills sold in the United States between 2006 and 2012, showing that some six companies distributed 75 percent of the pills during that period.


Budget 2019 Needs To Have A Holistic View On Where Education In India Needs To Go

by Chirantan Chatterjee, Eric Hanushekvia The Indian Express
Wednesday, July 3, 2019

With the new Indian government shortly coming up with its first full federal budget and with education sector outlays being actively discussed, it is time to take a broader, holistic view of where Indian education needs to go. Rabindranath Tagore, who was the first non-European and Indian to win the Nobel Prize in literature in 1913, once noted, “Don’t limit a child to your own learning, for he was born in another time”.